Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Boundless Bio, Inc. (BOLD) had Consolidated Net Income/Loss of $-15.68M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-15.68M |
|
-- |
|
-- |
|
$17.06M |
|
$-17.06M |
|
$1.39M |
|
$-15.68M |
|
$-15.68M |
|
$-15.68M |
|
$-15.68M |
|
|
Consolidated Net Income/Loss |
$-15.68M |
$-15.68M |
|
$-17.06M |
|
$-16.74M |
|
22.36M |
|
22.36M |
|
$-0.70 |
|
$-0.70 |
|
| Balance Sheet Financials | |
$129.69M |
|
$3.79M |
|
$49.76M |
|
$179.45M |
|
$9.21M |
|
$47.55M |
|
$47.55M |
|
$56.76M |
|
$122.69M |
|
$122.69M |
|
$122.69M |
|
22.39M |
|
| Cash Flow Statement Financials | |
$-26.36M |
|
$14.35M |
|
$0.12M |
|
$27.15M |
|
$15.26M |
|
$-11.89M |
|
$3.49M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.08 |
|
-- |
|
-- |
|
0.28 |
|
0.40 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-26.47M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.78% |
|
-12.78% |
|
-8.73% |
|
-9.21% |
|
$5.48 |
|
$-1.18 |
|
$-1.18 |
|